SinoMab BioScience Limited (3681.HK) - Stock Prices, Stock Peers & Analysis

Home
3681.HK

Company Name	SinoMab BioScience Limited
Symbol	3681.HK
Currency	HKD
Price	1.23
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,329,241,935
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.03 - 1.95
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Shui On Leung
Website	https://www.sinomab.com

An error occurred while fetching data.

About SinoMab BioScience Limited

SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA),